These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18622261)

  • 1. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.
    Innocenti F; Liu W; Fackenthal D; Ramírez J; Chen P; Ye X; Wu X; Zhang W; Mirkov S; Das S; Cook E; Ratain MJ
    Pharmacogenet Genomics; 2008 Aug; 18(8):683-97. PubMed ID: 18622261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.
    Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F
    Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants.
    Ménard V; Eap O; Roberge J; Harvey M; Lévesque E; Guillemette C
    Pharmacogenet Genomics; 2011 Oct; 21(10):631-41. PubMed ID: 21881541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population.
    Saeki M; Saito Y; Jinno H; Tanaka-Kagawa T; Ohno A; Ozawa S; Ueno K; Kamakura S; Kamatani N; Komamura K; Kitakaze M; Sawada J
    Drug Metab Dispos; 2004 Sep; 32(9):1048-54. PubMed ID: 15319348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variations in UDP-glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean population.
    Hwang MS; Lee SJ; Jeong HE; Lee S; Yoo MA; Shin JG
    Drug Metab Pharmacokinet; 2010; 25(4):398-402. PubMed ID: 20814162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation.
    Nakamura A; Nakajima M; Higashi E; Yamanaka H; Yokoi T
    Pharmacogenet Genomics; 2008 Aug; 18(8):709-20. PubMed ID: 18622263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity.
    Duguay Y; Báár C; Skorpen F; Guillemette C
    Clin Pharmacol Ther; 2004 Mar; 75(3):223-33. PubMed ID: 15001974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects.
    Saito K; Moriya H; Sawaguchi T; Hayakawa T; Nakahara S; Goto A; Arimura Y; Imai K; Kurosawa N; Owada E; Miyamoto A
    Clin Biochem; 2006 Mar; 39(3):303-8. PubMed ID: 16466707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
    Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
    Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms and haplotypes of the UDP-glucuronosyltransferase 2B7 gene promoter.
    Hu DG; Meech R; Lu L; McKinnon RA; Mackenzie PI
    Drug Metab Dispos; 2014 May; 42(5):854-62. PubMed ID: 24561451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
    Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
    Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activity.
    Jones NR; Sun D; Freeman WM; Lazarus P
    J Pharmacol Exp Ther; 2012 Sep; 342(3):720-9. PubMed ID: 22661630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
    Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy.
    Hirota T; Ieiri I; Takane H; Sano H; Kawamoto K; Aono H; Yamasaki A; Takeuchi H; Masada M; Shimizu E; Higuchi S; Otsubo K
    Drug Metab Dispos; 2003 May; 31(5):677-80. PubMed ID: 12695358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance.
    Bhasker CR; McKinnon W; Stone A; Lo AC; Kubota T; Ishizaki T; Miners JO
    Pharmacogenetics; 2000 Nov; 10(8):679-85. PubMed ID: 11186130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid.
    Bernard O; Tojcic J; Journault K; Perusse L; Guillemette C
    Drug Metab Dispos; 2006 Sep; 34(9):1539-45. PubMed ID: 16790554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants.
    Yang ZZ; Li L; Wang L; Yuan LM; Xu MC; Gu JK; Jiang HD; Yu LS; Zeng S
    Acta Pharmacol Sin; 2017 Aug; 38(8):1184-1194. PubMed ID: 28552915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7.
    Stone AN; Mackenzie PI; Galetin A; Houston JB; Miners JO
    Drug Metab Dispos; 2003 Sep; 31(9):1086-9. PubMed ID: 12920162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte nuclear factor-1alpha is a causal factor responsible for interindividual differences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers.
    Toide K; Takahashi Y; Yamazaki H; Terauchi Y; Fujii T; Parkinson A; Kamataki T
    Drug Metab Dispos; 2002 Jun; 30(6):613-5. PubMed ID: 12019184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.